ER = estrogen receptor, MSI = microsatellite instability, CIN = chromosomal instability, HPV = human papilloma virus, BM = bone marrow metastasis

Data Set	PubMed ID	Cancer Type	Array Type	Groups (Number of Samples)	Number of Probes	Number of Regions	CGHpower
Chin et al.	17925008	breast	spotted oligo	ER+ (113) vs. ER- (57)	26,755	223	Output
Douglas et al.	15256451	colorectal	BAC	MSI (7) vs. CIN (30)	3,032	142	Output
Fridlyand et al.	16620391	breast	BAC	TP53+ (10) vs. TP53- (52)	1,877	231	Output
Myllykangas et al.	18506690	gastric	cDNA	diffuse (15) vs. intestinal (23)	11,342	260	Output
Nymark et al.	16740712	lung	cDNA	asbestos-exposed (11) vs. non-exposed (9)	10,953	242	Output
Postma et al.	19150955	colorectal	spotted oligo	good (16) vs. bad response (16)	26,755	111	Output
Smeets et al.	16314836	head and neck	BAC	HPV+ (12) vs. HPV- (12)	4,196	143	Output
Wrage et al.	19208797	lung	spotted oligo	BM+ (13) vs. BM- (15)	25,549	23	Output
Simulation 0			in-situ oligo	(15) vs. (15)	42,331	440	Output
Simulation 1			in-situ oligo	(15) vs. (15)	42,331	462	Output
Simulation 2			in-situ oligo	(15) vs. (15)	42,331	457	Output
Simulation 3			in-situ oligo	(15) vs. (15)	42,331	461	Output
Simulation 4			in-situ oligo	(15) vs. (15)	42,331	492	Output
Simulation 5			in-situ oligo	(15) vs. (15)	42,331	489	Output
Simulation 6			in-situ oligo	(15) vs. (15)	42,331	501	Output
Simulation 7			in-situ oligo	(15) vs. (15)	42,331	501	Output
Simulation 8			in-situ oligo	(15) vs. (15)	42,331	490	Output
Simulation 9			in-situ oligo	(15) vs. (15)	42,331	507	Output
Simulation 10			in-situ oligo	(15) vs. (15)	42,331	525	Output